Acetaminophen Risk Management On Tap For Joint Advisory Panel
This article was originally published in The Tan Sheet
Executive Summary
FDA is looking for risk-management solutions to liver problems linked to the misuse of acetaminophen in OTC and prescription products, and will convene a joint advisory panel to discuss potential steps to take